The extraction, purification, and refinement of important bioproducts are crucial tasks for the downstream processing market in the dynamic fields of industrial biotechnology and biopharmaceuticals.

According to MarketsandMarkets™, the Human Microbiome Manufacturing Services Market is projected to grow from about USD 0.11 billion in 2025 to USD 0.27 billion by 2031, at a CAGR of 16.7%.

Willow Biosciences – one of a clutch of biotech firms producing cannabinoids via biosynthesis rather than extraction – has started strain optimization and process development for commercial production ...

As per recent market analysis, the global downstream processing industry growth is set to witness an impressive growth trajectory, estimated to reach a substantial value of US$ 72.3 billion by the end ...

Fumaric acid is a versatile dicarboxylic acid with applications spanning the food, pharmaceutical, and polymer industries. Traditionally produced from petrochemical processes, recent endeavours have ...